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Previous work by Wishart et al. (in press) and others [( 1989) J. Map Reson. 83.441449; (1990) J. Magn. Rcson. 90. 165-1761 has shown a strong 
tendency for protein secondary structure to be manifested in ‘H NMR chemical shifts. Based on these earlier results. two techniques have been 
developed for the quantification of secondary structure in proteins. Both methods allow for the rapid and accurate determination of the percent 
content of helix, coil, and P-strand based on the integration (or peak enumeration) of selected portions of either I-D or 2-D ‘H NMR spectra. 
These new and very simple procedures have been found to compare quite favorably to other well established techniques for secondary structure 
determination such as CD. Raman and IR spectroscopy. 
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1. INTRODUCTION 
X-ray crystallography and. more recently, NMR 
spectroscopy have permitted biochemists to study the 
structure and conformation of peptides and proteins 
with unprecendented etail. However, structural deter- 
mination and conformational analysis using these two 
techniques often requires many months, if not years, of 
painstaking work. Furthermore, the complexity of these 
procedures often limits the accessibility of such tech- 
niques to all but a few specialists. As a result, there is 
still a very strong demand among many protein 
chemists to seek more ‘user-friendly’ spectroscopy 
methods to conduct their own, lower resolution, con- 
formational studies without the inconvenience of these 
more time-consuming techniques. Perhaps this, in part, 
explains the continued popularity and widespread use 
of CD, Raman and IR spectroscopy in protein chemis- 
try to this day. Indeed, all three of these optical techni- 
ques permit quantitative, medium-resolution charac- 
terizations of protein structure within the time-frame of 
a single day. 
or infrared spectroscopy. Indeed, a number of compari- 
sons suggest that these new NMR methods may be 
more accurate and their implementation far easier than 
for CD, Raman or IR. Whereas these optical methods 
often require specialized software packages to conduct 
Fourier deconvolution [2]. singular value decomposi- 
tion [3.4] or multi-variate constrained regularization [5], 
this new NMR approach requires little more than an 
ability to count peaks or to integrate over peak areas. 
The impetus to develop such an NMR approach 
began with attempts to find practical applications for 
the previously reported chemical shift tendencies found 
for amino acids in a-helices. P-strands and coils [ 1,6,65]. 
This work has already led to a number of other useful 
developments concerning chemical shift and protein 
structure but it is this particular application of second- 
ary structure quantitation that we wish to report here. 
2. MATERIALS AND METHODS 
In this paper we wish to demonstrate how NMR 
spectroscopy can provide the same quantitative assess- 
ment of protein structure within the same time-frame 
and with equal accuracy and ease as either CD. Raman 
ADbrevia/iorr.s: NMR, nuclear magnetic rcsonancc; NOE, nuclear 
Ovcrhauscr effect; COSY. two-dimensional corrclatcd spectroscopy; 
CD. circular dichroism spectroscopy: IR. infrared spectroscopy. 
Two methods arc prcscnted for the direct quantitation of protein 
secondary structure. Method I is for the quantitation of secondary 
struclurc through I-D ‘H NMR while Method 2 is for thcquantitation 
of secondary structure through 2-D ‘H NMR. I3oth tcchniqucs arc 
csscntially empirical in nature and both arc based on the integration 
of peaks in selected regions of the a-proton and amide/aromatic 
regions of ‘H NMR spectra. In order to USC cithcr tcchniquc the 
protein of intcrcst must meet scvcral criteria, It must bc: (i) water 
soluble; (ii) slablc at pH 6.0 or Icss. and (iii) hitVC its full scqucncc or 
amino acid content known. 
C’urrr*s~o&e,rcc otklrcss: D.S. Wishart. Department of Molccul;lr I3io- 
physics and Uiochcmisrry, Yale University, New Haven. CT 06.51 I, 
USA. 
Dcvclopmcnt and testing of both proccdurcs have been based 
primarily on a datnbasc of protein chemical shift values ;Ind secondary 
S1ructurc i~ssignmcnts collcctcd from a variety of published sources. 
Thcsc arc listed in TnblC I. Secondary structure assignnrcnts for np- 
proxim;ltcly half of the listed proteins wcrc supplcnrcotcd or corro- 
borntcd by additional crystallographic data obtained from 111~ Urook- 
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haven Protein Data Bank [66] as well as from several previously 
published structural databases [67,68]. A more detailed discussion of 
the secondary structural assignments is given in [I J. A database con- 
taining the ‘H chemical shift assignments and secondary structures of 
more than 70 proteins is available from the authors upon request. 
2. I. Method I 
This protocol has been specifically designed for the determination 
of protein secondary structure content through simple integration of 
one-dimensional ‘I-f NMR spectra. Fig. I illustrates the central idea 
behind this particular approach. As can be seen from this figure, it is 
necessary to collect 2 identical spectra for the protein of interest, I in 
I&O and another in H,O. This may be done by dividing the original 
protein sample in two equal portions. lyophilizing each and then 
redissolving one aliquot in 90% HzO/lO% D:O and the other in an 
equal volume of 99.9% D1O. Alternatively it is possible to 'recycle' just 
I sample (as was done for this pork) through each of the 2 solvent 
conditions. This can gencmlly be done without any loss in accurary. 
In both cases it is necessary to collect the 2 spectra under identical 
conditions (temperature. pH, number of scans, resolution. spectral 
width, relaxation delays etc.). 
The ‘H spectrum collected in HI0 is used for integrating over 
portions of the amide region while the ‘H spectrum collected in DZO 
is used for integrating over portions of the &‘H region. To be assured 
that all protons in the amide region are at their fullest intensity (in the 
HI0 spectrum) it is necessary to work under restricted pH conditions 
and to use either ‘mild’ saturation of the solvent resonance or tailored 
excitation of the protein resonances. Likewise, in order to shift the 
HDO resonance (in the D20 spectrum) far enough away from the a-‘H 
envelope it is usually necessary to work under slightly elevated temper- 
atures. Hence, by maintaining the pH between 3.040 and by keeping 
the temperature between 2535°C. both requirements may be met. In 
general. these are not very restrictive conditions for most proteins. 
It has been determined. through a series of tests and collected 
Fig. I, ‘H spectrunl of rat parvalbumin collcctcd on a Varian VXR 500 MHZ spcctromctcr. The top spectrum was collcctcd in Y9.9% D20 while 
IIIC bottom spectrum Wits collcctcd in 90% H~U/lO% DIO. The spectral swccpwidth for both was 7000 Hz and the relaxation delay was set to 4.0 s. 
The Hz0 rcsonancc was supprcsssd by simple prcsaturation. The pli for this sanqAc \WS 4.G and the pratcin concentration approximately 1.5 mM. 
Uoth spcclm L’ : *ollcctcd at 30°C using ;I total of 32 sc;ms each. lntcgrotion was pcrformcd after basclinc correction and eppropriatc scaling. 
Values of II . SC. integrals (corresponding to the cstimatcd nunrbcr of resonance) arc printed above each region (4,85-5.90 ppm and 8.?0~~9,00 
ppm). 
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Table I 
Summary of peptides and proteins used in development and testing of Methods I and 2 
Protein (f$ of residues) Source Conditions 
PH oc 
November 1991 
Reference” 
Acyl Carrier Protein (77) 
oz Bungarotoxin (74) 
CL Neurotoxin (60) 
Q Purothionin (45) 
Anaphylotoxin C3a (77) 
Anaphylotoxin C5a (75) 
Anenome To;;in BDS ! (43) 
Antennapedia Homeo (68) 
Anthopleurin A (49) 
Apamin (18) 
Arc Repressor (53) 
Bull Seminal Inhibitor (57) 
Calbindin (76) 
Caimodulin (148) 
Cardiotoxin CTX II (60) 
Cecropin A (37) 
Cellobiohydrolase I (36) 
Cro repressor (66) 
Cytochrome BS (82) 
Cytochrome C (104) 
Cytochrome C2 (116) 
Cytochrome C55 1 (82) 
Elgin C (69) 
Flavodoxin (137) 
Hirudin (65) 
Histidine Cont. Protein (85) 
Histonc H5 (77) 
Insulin (51) 
Interleukin 1-B (153) 
lntcrleukin 8 (72) 
Lac Repressor (51) 
Leucine Zipper GCN4 (33) 
Lysozyme (129) 
Lysozyme (I 30) 
Lysozyme ( 164) 
Ner Protein (69) 
Neutrophil Peptide 5 (33) 
Ovomucoid 3d Domain (56) 
Parvalbumin (108) 
Plastocyanin (97) 
Procarboxypeptidase (81) 
Protein EL-30 (58) 
Ribonuclease A (I 24) 
Ribonuclease Tl (104) 
Staph. Nuclease (I 36) 
Tendamistat (74) 
Thioredoxin (105) 
Thioredoxin (108) 
Trypsin Inhibitor (62) 
Trypsin Inhibitor (58) 
Ttypsin Inh. Type E (59) 
Trypsin Inhibitor (28) 
Ubiquitin (76) 
E. coli 6.1 25 
B, rnulticinctus 4.0 35 
D. polylepsC 4.2 36 
Wheat 4.0 25 
Bovine 5.5 27 
Bovine 2.3 IO 
A. &rata 3.0 27 
D. tnelanogasrer 4.3 20 
A. xattthogratnmic :e 4.5 27 
A. mellifera 2.0 25 
Phage P22 5.4 50 
Bovine 4.9 45 
Porcine 6.0 27 
D. tttelanogasler 6.3 47 
N. rnossambico 3.6 45 
H. cecvopia 5.0 25 
T. reesei 3.9 27 
Phage 1 6.8 35 
Bovine 4.0 40 
Horse 5.8 40 
R. capsulatus 6.0 30 
R. aeruginosa 3.5 32 
Leech 3.0 36 
M. elsdenii 8.3 43 
H. tnedicinalis 3.0 25 
E. coli 6.5 30 
Chicken 3.7 25 
Human 3.6 27 
Human 5.4 36 
Human 5.2 40 
E. coli 6.9 I8 
Yeast 5.0 20 
Chicken 3.8 35 
Human 3,8 35 
Phage T4 5.6 20 
Phage p 7.0 27 
Rabbit 3.5 20 
Turkey 4.2 25 
Pike 6.1 62 
S. obliquus 6.2 30 
Bovine 6.5 I5 
E. coli 3.5 35 
Bovine 3.2 30 
A. ory:ae 5.5 40 
S. aureus 7.4 37 
S. lendae 3.2 50 
Human 5.5 40 
E. coli 5.7 35 
Ascaris 2.4 40 
Bovine 4.6 68 
D. polylepsis 3.2 50 
Squash 2.0 32 
Human 4.7 50 
“References arc primarily to sources containing rcsonancc assignments and preliminary secondary slructural information. 
statistics from numerous proteins [I], that the number of rcsonanccs Additional work has also rcvealcd that the numbcrof rcsonancc found 
found between 8.20 and 9.00 ppm in the ‘full intensity’ amide cnvclopc bctwccn 4.85-5,90 ppm is almost always equal to half the number of 
is approximately equal to 90% of the number of ‘coil’ rcsiducs in a rcsiducs ie /?-strands. It thcrcforc stands to reason that by integrating 
protein. Note that this range of 8.20-9.00 ppm is almost identical to from 4.85-5.90 ppnt and from 8.20-9.00 ppm and by scaling thcsc 
the range for ‘random coil’ amide protons quoted by Witrich [7]. intcgrnls approprimcly it is possible to accurately dctcrminc the p- 
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strand content. the coil content and. by default, the a-helix content of 
almost any protein. 
Accurate integration and careful scaling are absolutely vital to the 
success of this method. It is therefore important to pay particular 
attention to baseline distortion and to correct for it when necessary. 
It is also important to collect a sufficient number of scans to get 
adequate (= 50: I) signal intensity so as to ensure accurate integration. 
Scaling may bc done most conveniently by looking for a well-resolved 
single peak (such as isolated cr-proton. a distinctive up&Id methyl 
group, a single histidine resonance. or an isolated amide) and ad,iusting 
the integral scale accordingly. Alternatively. for very large proteins. 
(where single resonances are almost impossible to identify) it is pos- 
siblc to scale quite accurately by integrating over the whole amide 
region (6.0-I I .O ppm) and equating this measured value to the total 
number of amide and aromatic protons known to be in the protein. 
This ‘total downfield ‘H content’. Ndown. is given by: 
N ,,_.“=#res + (2x#N) + (2x#Q) + (Sx#H) + (4x#Y) + (Sx#F) + 
(6x#W) 
where #res is the total number of residues (excluding prolines). and 
#N. #Q. #H etc. represent the number of amide or aromatic ring- 
bearing amino acids found in the protein (using the standard single 
letter code for amino acids). 
To summarize, the step-by-step protocol for quantifying secondary 
structure content via one-dimensional ‘H NMR is as follows. 
I. Prcparc two identical samples of the protein of interest. One 
sample should be dissolved in a defined volume of 90% H,OIlO% D?O. 
the second should be dissolved in an identical volume of 99.9% D?O. 
Both samples must be at equal concentrations. After adjusting the pH 
(which should be bctwcen pH 3.0-6.0). collect standard one-dimensio- 
nal ‘H spectra of both samples using identical collection conditions. 
2. After performing the necessary baseline corrections and the re- 
quircd scaling. USC direct integration to determine the number of 
resonances between 8.20-9.00 ppm for the HZ0 sample. Call this value 
CC>. (Note that since the spectra were collected in 90% H:O, this 
integral will actually represent 90% of the total number of resonances 
between 8.20-9.00 ppm and should thcreforc bc equal to the number 
of residues in the coil configuration.) 
3. After performing the necessary baseline corrections and Ihc rc- 
quircd scaling. USC direct integration to determine the number of 
resonances bcIwcen 4.85-5.90 ppm for the D:O sample. Call this va!ue 
<B>. 
4. The number of r&dues in the coil configuration is given by: 
#coil=<0 
The number of rcsiducs in the p-strand configuration is given by: 
The number of residues in the a-helix configuration is given by: 
#a=#rcsiducs+-#coil 
The ;~cIual portion of secondary structure is given as: 
##coil 
%coil = ~ #P %/3 = ~ %a = #a 
#rcsiducs #rcsiducs #rcsiduc=i 
(Whcrc #rcsiducs is the total number of rcsiducs in the protein or 
pcptidc.) 
Thcrc arc scvcral c;wcats and cautions that bear mentioning, tl~csc 
arc as follows: (il lfonc finds that #a<O. then set #a=(). Calculate the 
pcrccntage of/7-strand and coil using lhc formulc %~=#~/(#/3*#coil) 
and %coil=#coil/(#~+#coiI): (ii) If one finds thcrc arc no peaks bc- 
1wcc1~ 4.X5.-S.YO ppm (i.c.<B>=O) then set #+O: (iii) Due I0 llrc 
statistical and empirical ntiturc of this method. peptidss wiIh fcwcr 
than 40 rcsiducs arc likely to give spurious rcwltz. 
2.2. MrrkoJ 2 
This protocol was specifically designed for the determination of 
protein secondary structure content through regional integration 
(peak counting) in the ‘fingerprint’ region OF two-dimensional COSY 
or DQF-COSY ‘H NMR spectra. While generally limited to smaller 
proteins, Method 2 does offer several advantages over Method I. For 
example. rather than having to collect spectra from two identical 
samples dissolved in different solvents. it is possible to get the same 
kind of information using just a single spectrum collected with the 
sample dissolved in a single solvent (Hr.0). Furthermore. rather than 
having to conduct very careful intcgrahons to get the necessary peak 
intensities it is possible to simply count the visible COSY peaks to get 
the same kind of information. Additionally. because the fingerprint 
region actually separates a-protons fromb-protons (which is not done 
in one-dimensional spectra) it is possible to make USC of a much better 
method to calculate the o-helix content. This helix content mcasure- 
ment. which is also empirically derived, is based on the observation 
that the number of helical residues in a protein is proportional to the 
number of or-protons (excluding glycincs) between 3.404. IO ppm [I]. 
Fig. 2 illustrares the centml idea behind Method 2. Each shaded 
region represents the portion of the spectrum which has been found 
to corrclatc with the content of a-heliccs,/7-strands and coils. Count- 
ing peaks in each of the differently shaded regions (note that some 
ileaks are actually counted twice) will give one a rather accurate 
assessment of the secondary structure content of the protein. 
For a mom specific outline of how the procedure should be conduc- 
ted, WC present the following itemized protocol. 
I. With Ihe protein of interest dissolved in HZ0 (ideally at pH ~6.0 
and a temperature >25”C). collect a 2-:3 CQSY or DQF-COSY ‘H 
NMR spectrum. 
2. Through direct peak counting in the tingcrprint region determine 
the number of resonances found between 8.20-9.00 ppm. The number 
of peaks in this spectral region is proportional to the number of 
residues found in the coil conformation. Cal Il.1 value ~0. 
3. Through direct peak counting in the lingerprint region determine 
the number of resonances found between 4.85-5.90 ppm. The number 
of peaks in this spectral region is proportional to the number of 
residues found in the p-strand conformation. Call this value <B>. 
4. Through direct peak counting in the fingerprint region determine 
the number of resonances found between 3.40-4.10 ppm. The number 
of peaks in this spectral region (after subtracting out the expected 
number of glycine peaks) is proportional to the number of residues 
found in the a-helix conformation. Call this value <A>. 
5. An estimate of the proportion of residues in the coil conliguration 
is given by: 
<#coil> = 0.9 CC> 
An cstimatc of the proportion of r&dues in B-strands is given by: 
<#@> = 2.0 (<B>) 
An estimate of Ihc proportion of rcsiducs in the a helix conhguration 
is given by: 
<#a> = 2.0 (-=A>-$.0 (#glycinc)} 
An cstimatc of the total number of rcsiducs is given by: 
TOT.ZL = <#coil> + <#p> + <#as 
‘fhc actual portion of secondary structure is given as: 
#coil 
Qcoil = - 
TOTAL 
%/3 = 3C %a =#a 
TOTAL TOTAL 
(Whcrc ftrcsiducs is the total number of rcsiducs and #glycinc is the 
number of glycincs know to bc in the pcptidc or protein.) 
As bcforc, thcrc arc II few other caveats and cautions that bear 
further mctnion: (i) It has been found that the rcsultscould bc slightly 
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Fig, 2. Fingerprint rcgion of a DQF-COSY spectrum ot’E. co/i rhiorcdoxin collccted at 3O’C in 90% H:O/IO% D?O. The shaded arcas correspond 
IO the regions of the spectrum which contain important structural information. The two hatched. vertical blocks merkcd by p and a correspond 
IO the arcas used IO cstimatc IIIC P-strand and a-helix content. rcspcc!ivcly. Tho hatched transvcrsc region marked by c is used IO csrimatc the coil 
conlcnt. NOIC that SOIIIC peaks appear in overlapping regions and hcncc arc counted twice when making secondary strucIurc’ cslimalcs. 
improved if the cstimatc of Ihc number of/I-strand rcsiducs is scaled 
according IO the poptide r.izc using the following equation: 
3. RESULTS 
<#B> = 2.0 (CUB-0.05 (#rcsiducs -60)) 3.1. Mcrlrod I 
As a general cheek of the utility and applicability of 
Method-I, the above proccdurc was applied to 6 protc- 
ins of widely differing sizes and folding classifications: 
rat purvulbumin ( 109 rcsiducs). ribonuolcasc A (124 rc- 
siducs). HEW lysozytnc (I 29 residues), troponin C (162 
rcsiducs), soybean trypsin inhibitor ( 18 I rcsiducs) and 
carbonic :tnhydri\sc (356 rcsiducs). It is intcrcsting to 
note that under the conditions used to collcst the tropo- 
nin C spectrum. this protein was almost complctcly di- 
mcrizcd so the ‘effcctivc’ nunrbcr of rcsiducs was proba- 
bly closer to 324. Fig, I illustretcs a typicil’ result, with 
This seems 11~ corrccl for the prcpondcrancc of cystcinc and glycinc 
rcsiducs found iu very small prorcins (which tend to have ll~w-v~~ltI~dS 
upficld chcmicul shifis). It is not clear ifrhiscorrccrion gcncrxlly holds 
for much larger proteins (> IS kDa). (ii) If, in us;ng Method 2. one 
finds thcrc arc nu pci\ks hcl\vccn 4.85.S.YO ppm (ix. <U>=O) thrn SCI 
#p=O. (iii) The procudurc works best for proteins whcrc assigmncnts 
IIiIVC been cerricd out bclwccn pi-1 3.0.7.0 and IcmpcraIurcs bct\vccn 
X5O”C. (iv) Ms~hod 2 appccrs to bc gcncrally applkxblc lo prpridcs 
iIlld prolcins with molecular weights ~20 kDa, howcvcr. dur IO 111~ 
St;~liSliC;ll b;tsis irnd cmpiricxl nalurc of the Icchnicluc. pcptidcs Of 
fcwcr than 40 rcsiduss sonictinV2s give spurious rcsuils. 
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scaled integrals included, as obtained for rat parval- 
bumin. 
Table II compares the estimates of secondary struc- 
ture content obtained by Method 1 with those obtained 
by crystallography for these 6 proteins. With the excep- 
tion of soybean trypsin inhibitor, the agreement is 
rather good. There is a slight tendency to underestimate 
the coil content in larger proteins and this may be due 
to the level of saturation transfer that takes place during 
the presaturation of the H,O resonance. This presatura- 
tion Ieads to generally reduced amide intensities and 
hence to a smaller value for the integrated area under 
the 8.20-9.00 ppm envelope. Perhaps a more refined 
solvent suppression technique or, alternatively, a more 
refined selective excitation protocol would help in these 
mtters. 
The success of this technique for proteins ranging in 
size up to 324 residues indicates that the method has the 
potential to be applicable to proteins of almost all sizes. 
However, given the small size of the experimental sam- 
ple, it was felt that additional data would have to be 
accumulated before we could be confident of the 
method’s general applicability. 
As a further check of this method, idealized data of 
integrated peak areas were generated using the chemical 
shift assignments of ‘solved’ proteins which had been 
previously published in the literature. Note, however. 
that no attempt was made to correct for possible line- 
width differences within this ‘simulated’ data set. These 
values were then used to calculate the percent content 
of secondary structure employing the same methods 
described above. This permitted an effective compari- 
son to be conducted on more than 50 different proteins. 
The results of this tabulation are presented in Table III 
(column 2). It can be seen that the agreement o pre- 
vious structural assignments is quite good for nearly all 
of the listed proteins. This result, in combination with 
the actual experimental findings given in Table II sug- 
gests that this technique is, indeed. generally applicable. 
Further refinements in the methodology and additional 
studies on other proteins should help to improve its 
accuracy in the future. 
3.2. Merizod 2 
In Table III we also list the secondary structure esti- 
mates made using Metliod 2. These estimates may be 
compared with those obtained from X-ray crystallo- 
graphy which are presented in column I. With the cx- 
ception of few very small proteins. the agreement is 
rather striking, It is important to note, however. that 
most of the NMR data used in preparing this table was 
taken from published sequcntinl assignments and. as 11 
result. the data are somewhat idealized. Application of 
these procedures to actual COSY spectra from publish- 
ed sources, as well as those obtained locally. was also 
done in order to cheek the general validity of the 
method under simulated ‘cxpcrimcntal’ circumsL;~nccs. 
Very little disagreement was found. Clearly, however. 
it is important to collect high quality COSY spectra with 
good signal to noise ratio so as to be as certain as 
possible that nearly all expected resonances are visible 
in the fingerprint region. 
3.3. Comparison to CD, iR and Rarwn 
It was of some interest to compare the methods just 
described to other techniques which have traditionally 
been used in secondary structure quantification, nota- 
bly CD. IR and infrared Raman spectroscopy. Table IV 
presents a comparison between the secondary structure 
content as determined by Method 2 and the secondary 
structure content as determined by CD. The CD values 
were obtained from a variety of published sources while 
the X-ray values were obtained principally from 
[66,67,69]. If one compares the two sets of values with 
those obtained crystallographically, it is clear that 
Method 2 is significantly more accurate. A more limited 
comparison with IR and Raman data yielded similar 
results. 
While the success and simplicity of Method 2 is ob- 
vious, it is important to note that this procedure typi- 
cally requires an order of magnitude more material than 
does CD or other comparable forms of spectroscopy. 
This should not be overlooked when sample quantity or 
sample concentration is an issue. 
4. DISCUSSION 
The procedures outlined above provide two simple 
techniques for the rapid determination of secondary 
structure content in proteins. AII that is required is eith- 
er a regular 1-D or 2-D COSY spectrum of a protein 
dissolved in HZ0 (or D,O). Using simple peak counting 
(2-D COSY) or peak integration (1-D spectra) over a 
few selected regions of the spectrum it is quite possible 
to determine secondary structure content with an accu- 
racy that equals or exceeds that of such well established 
techniques as CD, IR and Raman spectroscopy. 
Table II 
Comparison of secondary structure content predictions from Method 
1 with those obtained by X-ray crystallography 
Protein name (# of rcsiducs) X-ray” Mcrhod 1 
lbrr mp SC %a s/3 %c 
Rat parv;tlburnin (109) 64 G 30 64 7 2s 
Ribonuclcasc A (124) 22 48 30 I6 44 39 
HEW Lysozyrnc (129) 45 19 3b 49 23 28 
Troponin C (I 62) G9 7 24 65 9 26 
Soybean Trypsin Inhibitor (181) 53 3 44 38 20 43 
Carbonic hnhydrasc (2%) 41 I3 4B 40 23 37 
?A%=% a-helix; “mp=S /3-slrimd: %c=% ‘coil’ 
“X-ray v;~Iucs wcr(: obtained from the PDD (661 and o~hcr published 
sources (67.683 
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Table iii 
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Comparison of predictions from Method I and Method 2 :o previously reported X-ray crystallographic and/or NMR measurements of secondary 
strucrurc 
Protein name (#residues) X-ray/NMR” Method lb 
%a %p %c %u %fl %c 
Method 2 
%a %j3 %c 
Acyl Carrier Protein (77) 
Algal Plastocyanin (97) 
d Bungarotoxin (74) 
a Neurotoxin (62) 
CL Purothionin (45) 
Anaphylotoxin C3a (77) 
Anaphylotoxin C5a (75) 
BDS I (43) 
Antennapedia (68) 
Anthopleurin A (49) 
Apamin (18) 
Arc Repressor (53) 
Ascaris Trypsin Inh. (62) 
Bovine Trypsin lnh. (58) 
Bull Seminal Inh. (57) 
Calbindin (76) 
Calmodulin (148) 
CTX II (60) 
Cecropin A (37) 
Cellobiohydrolase 1 (36) 
Cro Repressor (66) 
Cytochrome B5 (82) 
Cytochrome C (104) 
Cytochrome C55 I (82) 
Cytochrome C2 (I 16) 
Ner Protein (69) 
E. co/i Thioredoxin (108) 
Elgin C (69) 
Flavodoxin (137) 
HEW Lysozyme (129) 
Human Lysozymc (130) 
Hirudin (65) 
Histidine Protein (B5) 
Histonc HS (77) 
Human Thioredoxin (105) 
Insulin (51) 
Interleukin l/J (153) 
lnterlcukin 8 (72) 
Lac Repressor (51) 
Lcucinc Zipper GCN4 (33) 
T4 Lysozyme ( 164) 
NP-5 Peptide (33) 
Ovomucoid (56) 
Parvalbumin (108) 
Procarboxypcptidasc (81) 
Ribosomal EL-30 Prot. (53) 
PTI Type E (59) 
Ribonucleasc A (124) 
Ribonuclcasc TI (104) 
Squash Trypsin Inh. (28) 
Staph. Nuclcasc (I 36) 
Tcndamistat (74) 
Ubiquitin (76) 
61 0 39 67 5 28 68 5 27 
8 59 33 5 54 41 6 53 41 
0 51 49 2 59 39 0 61 39 
0 58 42 0 62 38 0 62 38 
35 22 43 SO 22 38 31 26 43 
69 0 31 66 3 31 66 3 31 
69 0 31 55 0 45 56 0 44 
0 56 44 12 42 46 0 47 53 
66 0 34 62 0 38 71 0 29 
0 49 51 18 49 33 0 60 40 
50 0 50 72 0 28 62 0 38 
53 17 30 45 17 38 55 I4 31 
0 55 45 16 48 36 7 54 39 
26 36 38 34 38 28 24 44 32 
I9 42 39 37 ‘5 3B* 18 32 50 
61 8 31 55 16 29 63 13 24 
62 B 30 61 9 30 58 IO 32 
0 62 38 0 63 37 0 63 37 
84 0 16 73 II 16 81 8 II 
0 45 55 25 33 42’ 0 44 56 
41 30 ‘9 4’ 27 31 44 26 30 
46 27 27 37 30 33 40 29 31 
49 6 45 61 6 33 57 7 36 
68 0 32 73 0 27 70 0 30 
51 5 44 61 3 36 56 4 40 
71 0 29 66 II 23 57 14 29* 
40 31 29 44 26 30 38 29 33 
22 42 36 23 42 35 7 51 42. 
42 35 23 50 28 22 37 35 ‘8 
45 19 36 47 23 30 35 29 36 
43 17 40 45 18 37 54 15 31 
0 38 62 34 22 44f 0 32 68 
41 36 23 28 4’ 30 37 37 26 
48 10 42 38 I6 46 50 13 37 
42 34 24 33 36 31 41 32 27 
58 IO 32 67 I2 ?I 67 I2 ?I 
0 60 40 0 58 42 I4 50 36 
21 42 27 I8 47 35 25 43 32 
64 0 36 61 0 39 64 0 36 
96 0 4 61 0 39 71 0 29 
64 13 23 64 6 30 60 6 34 
0 76 24 0 64 36 0 64 36 
23 36 41 34 II 45 5 31 64* 
64 6 30 7s 4 21 67 5 28 
27 35 3x 30 27 43 26 29 45 
31 33 36 31 ‘9 30 ‘3 39 38 
22 36 42 20 20 GO* 33 33 34 
22 48 30 IS 52 33 19 51 31 
I4 44 42 20 44 36 25 41 34 
0 64 36 0 56 44 0 56 44 
30 3x 32 33 38 29 36 30 28 
0 69 31 7 49 44 0 52 48 
26 41 3.1 16 4s 39 I6 45 39 
“Values obtnincd from X-ray cryrlallographic mcasurcmcnts, ucll-dclincd NMR structures or from previously puhlishcd rcporls on srcondary 
struclurc content mcasurcd by standard 2-D NMK methods 
‘D;~u for this column was obtained using ‘simulawd’ I-D NMR Jilta prcparcd rrom ilssignnlcnIs previously rcpnrtod in the litcraturc 
l lndiCatCs ill1 unusually poor prediction 
%=lt a-helix: a@=% /&strand: 9~2% ‘coil’ 
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Table IV 
Comparison of predictions from Method 2 to CD results 
- 
Protein name (#residues) Actual” Method 2 CD Referen& 
%CY %D %c %u %b %c %a %b %c 
Acyl Carrier Protein (77) 61 0 39 68 5 27 33 0 67 cz Purothionin (45) 35 22 43 31 26 43 54 2  26 t::; 
Anaphylotoxin C3a (77) 69 0 31 66 3 31 43 0 57 [631 
Anaphylotoxin C5a (75) 69 0 31 56 0 44 43 0 57 [631 
Bovine Trypsin Inh. (58) 26 36 38 24 44 32 21 28 51 
Calmodulin (148) 62 8 30 58 10 32 61 4 35 ;:; 
Cytochromc C (104) 49 6 45 57 7 36 33 9 58 [51 
E. coli Thioredoxin (I 08) 40 31 29 38 29 33 37 19 44 HEW Lys zyme ( 129) 5 I9 36 35 29 36 45 2  34 ::;I 
Human Thioredoxin (105) 42 34 24 41 32 27 49 35 I6 [541 
Insulin (51) 5g IO 32 67 12 21 49 23 27 r51 
Parvalbumin (108) 64 6 30 67 5 28 58 0 42 i51 
Ribonuclease A (124) 22 48 30 19 51 31 25 37 38 
Staph. Nuclease (136) 30 38 32 36 36 28 32 25 43 t:; 
“Values in the first column represent those taken from X-ray crystal slructures or published NMR structures. See [1,66-681 for more details or 
specific assignments 
hReferences to CD measurements 
%a=% a-helix; % B-strand: %c=% ‘coil’ 
Furthermore, unlike the complex manipulation and 
data ‘massaging’ that is generally required for the inter- 
pretation of IR, Raman and CD data, this new techni- 
que requires little more than simple peak counting: no 
curve fitting, second derivitization. deconvolution or 
transformation is needed. Furthermore, the procedure 
is not significantly affected by the ‘basis set’ or parame- 
terization prcblems that plague such techniques as CD 
or IR. Instead, this NMR-based procedure is simple, 
relatively unparameterized and fast. In fact, with a bit 
of practice it is quite possible (once the spectra are 
collected) to determine the secondary structure content 
of a protein in less than a few minutes. 
Although high-resolution NMR has reached a stage 
such that is now possible to determine the atomic struc- 
ture of a small protein to a great degree of accuracy, the 
procedure often requires many weeks, if not months, to 
do so. The possibility that NMR may now be used for 
a very quick determination or verification of secondary 
structure opens up a number of potential and highly 
useful applications. For instance, it s not hard to see 
how this procedure could be used in preliminary charac- 
terization of proteins for which detailed structural 
studies arc about to begin. It is also not difficult to see 
how this technique could bc adapted or extended to 
studies of titrated conformational changes in proteins 
(folding. unfolding etc.). Such work could be done 
cithcr in the fast or slow exchange limit, although the 
slow exchange studies may prove to bc more technically 
demanding. 
It is also worth noting that the same integration or 
peak-picking procedure for secondary structure deter- 
mination can be applied to other nuclei as well. Prelimi- 
nary work with13C carbonyl resonance assignments 
and/or one-dimensional 13C spectra for BPTI [69], cal- 
modulin [21] and E. coli thioredoxin has yielded some 
promising results. In particular, it has been found that 
the number of 13C carbonyl resonances found below 
172.0 ppm is proportional to the number of residues in 
P-strand configurations. In a like manner, the number 
of resonances found above 176.0 ppm is proportional 
to the number of residues in helical configurations. If 
a proper accounting of side chain carbonyl or carboxyl 
resonances is done, this procedure appears to be at least 
as accurate in secondary structure determination as the 
methods previously described for protons. It will be of 
some interest to explore this app’roach in greater detail 
as more ‘%Z spectroscopy is done in the future. 
To conclude, WC have demonstrated that it is possible 
to use NMR spectroscopy to quantify protein second- 
ary structure content with the same ease and swiftness 
ascan be done with more popular or more conventional 
techniques such as CD, IR or Raman spectroscopy. It 
is hoped that this application of NMR spectroscopy 
might be adopted by others, both specialist and non- 
specialist alike, as a useful and very simple method for 
characterizing protein structures and structural transi- 
tions in solution. 
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